Andrew Schiff

Andrew Schiff

Chairman bei MONTE ROSA THERAPEUTICS, INC.

Vermögen: 29 849 $ am 31.03.2024

58 Jahre
Health Technology
Health Services
Consumer Services

Profil

Andrew N.
Schiff
is currently the Chairman at Visiting Nurse Service of New York.
He is also the Non-Executive Chairman at Monte Rosa Therapeutics, Inc. since 2023.
In addition, he serves as an Independent Director at Aclaris Therapeutics, Inc. and as a Director at Planet Biopharmaceuticals, Inc., Henry Street Settlement, Inc., Planet Technologies, Inc., Dren Bio, Inc., and Aisling Capital LLC, where he has been the Managing Partner since 2000.
Previously, Dr. Schiff held positions as a Director at Bioenvision, Inc., Gilead Colorado, Inc., Barrier Therapeutics, Inc., CardioKine, Inc., and SkinMedica, Inc. He was also an Independent Director at Agile Therapeutics, Inc. from 2014 to 2016.
Additionally, he served as a Director at ArgiNOx Pharmaceuticals, Inc., PowerVision, Inc., Adams Respiratory Therapeutics, Inc., Sirion Holdings, Inc., Dynova Laboratories, Inc., Colorescience Corp., ZELTIQ Aesthetics, Inc., TransEnterix, Inc., Miramar Technologies, Inc., ARMGO Pharma, Inc., Cempra, Inc., Quintiles Transnational Holdings, Inc., Sirion Therapeutics, Inc., F2G Ltd., Zavante Therapeutics, Inc., Harmony Biosciences Holdings, Inc., and IQVIA RDS Asia, Inc.Dr. Schiff's education includes an undergraduate degree from Brown University, an MBA from The Trustees of Columbia University in The City of New York, and a doctorate from Weill Cornell Medical College.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
02.06.2023 24 072 ( 0,03% ) 29 849 $ 31.03.2024
31.03.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Andrew Schiff

UnternehmenPositionBeginn
ACLARIS THERAPEUTICS, INC. Director/Board Member 09.08.2017
MONTE ROSA THERAPEUTICS, INC. Chairman 01.06.2023
Director/Board Member -
Chairman -
Director/Board Member -
Private Equity Investor 01.01.2000
Director/Board Member -
Director/Board Member 09.07.2010
Alle aktiven Positionen von Andrew Schiff

Ehemalige bekannte Positionen von Andrew Schiff

UnternehmenPositionEnde
ZELTIQ AESTHETICS INC Director/Board Member 28.04.2017
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Sehen Sie sich die Erfahrung von Andrew Schiff im Detail an

Ausbildung von Andrew Schiff

Brown University Undergraduate Degree
The Trustees of Columbia University in The City of New York Masters Business Admin
Weill Cornell Medical College Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Andrew Schiff im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

35

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
AGILE THERAPEUTICS, INC.

Health Technology

ACLARIS THERAPEUTICS, INC.

Health Technology

HARMONY BIOSCIENCES HOLDINGS, INC.

Health Technology

MONTE ROSA THERAPEUTICS, INC.

Health Technology

Private Unternehmen28

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Electronic Technology

Health Technology

Finance

Health Technology

Retail Trade

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Technology Services

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Andrew Schiff